further confirmed that hypoxia participates in the pathogenesis of MS by modulating EndoMT-related genes, potentially involving transforming growth factor-β (TGF-β), NF-κB, TNF, and mTOR signaling pathways (171). The gene discussed is TGFB1; the disease is myeloid sarcoma.